This includes developing standardized protocols, fostering multidisciplinary collaboration, and providing robust patient education and support
The relationship between growth hormone, aging, and optimal function continues to be an active area of investigationwith both promise and important cautions
Current guidelines recommend GLP-1s for adults with obesity (BMI at or above 30), or adults with overweight (BMI at or above 27) plus a weight-related comorbidity such as type 2 diabetes, hypertension, fatty liver disease, or sleep apnea, for whom the cardiometabolic benefit of the medication exceeds its risks
Yes we have lifestyle interventions, and they work
The media (e.g., New York Times , Good Morning America ), food and nutrition brands (e.g., Nestle ), and medical providers have focused on the potential for SMM loss among persons treated with GLP-1 medications